|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.25 - 1.34|
|52 Week Range||1.05 - 3.00|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
ARCA biopharma Inc (NASDAQ:ABIO), a USD$14.69M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population and theRead More...
Michael Bristow took the helm as ARCA biopharma Inc’s (NASDAQ:ABIO) CEO and grew market cap to USD$14.69M recently. Understanding how CEOs are incentivised to run and grow their company isRead More...
If you are looking to invest in ARCA biopharma Inc’s (NASDAQ:ABIO), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...